Crossmark

Biomarkers for prediction of renal replacement therapy in acute kidney injury: a systematic review and meta-analysis

Crossref DOI link: https://doi.org/10.1007/s00134-018-5126-8

Published Online: 2018-03-14

Published Print: 2018-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Klein, Sebastian J.

Brandtner, Anna K.

Lehner, Georg F.

Ulmer, Hanno

Bagshaw, Sean M.

Wiedermann, Christian J.

Joannidis, Michael https://orcid.org/0000-0002-6996-0881
License Information

Text and Data Mining valid from 2018-03-01
More Information

Article History

Received: 13 December 2017

Accepted: 2 March 2018

First Online: 14 March 2018

Compliance with ethical standards

:

: SJK, AKB, GFL, and HU report no conflict of interest. SMB declares receiving honoraria as a speaker and consultant and research support from Baxter Healthcare Corp. He was a co-investigator in renal biomarker studies. CJW declares receiving honoraria as a speaker for Kedrion, CSL Behring, Baxter, and Grifols and as a consultant for CSL Behring and Grifols. MJ has received honoraria or research support from Baxter Healthcare Corp, AM-Pharma, CLS Behring, Fresenius, and Astute Medical. He was a co-investigator in renal biomarker studies.